Modifying the physical characteristics of microscopic biomaterials to interact seamlessly with the body's tissues could unlock safer and more effective cancer treatments, according to Virginia Tech ...

Modifying the physical characteristics of microscopic biomaterials to interact seamlessly with the body's tissues could ...

In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and ...

The following is a summary of “Association of Sleep Traits With Venous Thromboembolism: Prospective Cohort and Mendelian Randomization Studies,” published in the January 2025 issue of Hematology by Li ...

Outpatient management of patients with cancer-associated pulmonary embolism (PE) may be a feasible, safe approach with low short-term rates of recurrent venous thromboembolism (VTE), major bleeding, ...

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...

The human genome encodes potentially thousands of tiny proteins that were previously overlooked. The search is on to find out ...

People with medullary cancer may have a germline mutation, so family members of these patients should have access to genetic screening. How is thyroid cancer treated? Thyroid cancer treatment is ...

Far from simply sharing information, Dr. Lin’s work reshapes the way we approach patient safety, setting a new standard for proactive care and DVT prevention. VTE prevention begins with awareness and ...

which two-thirds of all cancer patients will receive at some point in their treatment journey. Typically delivered through administering a beam of X-rays or other particles over the course of two ...

A large number of cancer patients are unaware of the increased ... arterial insufficiency or open wound VTE prophylaxis should be continued throughout the hospital stay. It is recommended that ...

Cancer pts who have undergone major surgery or had previous VTE should continue prophylaxis with an LMWH after discharge for up to 28 days. a CNS = central nervous system, GI = gastrointestinal ...